Article Results (Showing 1 - 10 of 149) RSS Alert
-
Pipeline previews
Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatological community....
Journal of Drugs in Dermatology, 07/01/08 by Marissa Heller · More from publication -
Pipeline previews
Pipeline Previews brings to you information on the newest drugs and medical products as they become available to the dermatological community....
Journal of Drugs in Dermatology, 06/01/08 by Marissa Heller · More from publication -
Pipeline previews
Pipeline Previews brings you information on the newest drugs and medical products as they become available to the der-Teratologic community,...
Journal of Drugs in Dermatology, 05/01/08 by Marissa Heller · More from publication -
Onset Therapeutics and Anestafoam
Onset Therapeutics recently announced the marketing of Anestafoam[TM], a topical foam that contains lidocaine 4%. Anestafoam is the first and only...
Journal of Drugs in Dermatology, 04/01/08 by Marissa Heller · More from publication -
Onset Therapeutics and genital warts
Onset Therapeutics has recently applied to the FDA for approval for a novel product to be used in the treatment of external genital warts. The...
Journal of Drugs in Dermatology, 04/01/08 by Marissa Heller · More from publication -
Orphan drug designation for ADH-1
The FDA has granted orphan drug designation for ADH-1 from Adherex Technologies, Inc. The designation will allow ADH-1 to be used in combination...
Journal of Drugs in Dermatology, 04/01/08 by Marissa Heller · More from publication -
Oncophage for metastatic melanoma
Antigenics, Inc recently announced the completion and publication of results from its phase 3 trial of Oncophage[R] (vitespen), a cancer vaccine,...
Journal of Drugs in Dermatology, 04/01/08 by Marissa Heller · More from publication -
Interleukin 12/23 monoclonal antibody in the treatment of psoriasis
A recent report indicates that ABT-874, a fully human interleukin 12/23 monoclonal antibody, is safe and efficacious in the treatment of moderate...
Journal of Drugs in Dermatology, 04/01/08 by Marissa Heller · More from publication -
Centocor and ustekinumab
Centocor, Inc recently announced that its Biologics License Application (BLA) for ustekinumab (CNTO 1275) has been accepted for filing by the FDA...
Journal of Drugs in Dermatology, 04/01/08 by Marissa Heller · More from publication -
GentleWaves LED Photomodulation System for periorbital wrinkles
The FDA has granted 510(k) over-the-counter clearance to Light BioScience, LLC for the sale and marketing of its photomodulation system,...
Journal of Drugs in Dermatology, 04/01/08 by Marissa Heller · More from publication
